Delaware | 82-2758923 | ||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common stock, $0.01 par value | AVTR | New York Stock Exchange | ||||||||||||
6.250% Series A Mandatory Convertible Preferred Stock, $0.01 par value | AVTR PRA | New York Stock Exchange |
Page | |||||
Description
|
|||||
we, us, our | Avantor, Inc. and its subsidiaries | ||||
2019 Plan | the Avantor, Inc. 2019 Equity Incentive Plan, a stock-based compensation plan | ||||
Adjusted EBITDA | our earnings or loss before interest, taxes, depreciation, amortization and certain other adjustments | ||||
Annual Report | our annual report on Form 10-K for the year ended December 31, 2020 | ||||
AMEA | Asia, Middle-East and Africa | ||||
AOCI | accumulated other comprehensive income or loss | ||||
CARES | the Coronavirus Aid, Relief, and Economic Security Act | ||||
CERCLA | Comprehensive Environmental Response, Compensation, and Liability Act | ||||
cGMP | Current Good Manufacturing Practice | ||||
COVID-19 | Coronavirus disease of 2019 | ||||
double-digit | greater than 10% | ||||
EURIBOR | the basic rate of interest used in lending between banks on the European Union interbank market | ||||
FASB | the Financial Accounting Standards Board of the United States | ||||
GAAP | United States generally accepted accounting principles | ||||
high single-digit | 7 - 9% | ||||
LIBOR | the basic rate of interest used in lending between banks on the London interbank market | ||||
low single-digit | 1 - 3% | ||||
MCPS | 6.250% Series A Mandatory Convertible Preferred Stock | ||||
mid single-digit | 4 - 6% | ||||
PPE | personal protective equipment | ||||
RSU | restricted stock unit | ||||
SEC | the United States Securities and Exchange Commission | ||||
SG&A expenses | selling, general and administrative expenses | ||||
Specialty procurement | product sales related to customer procurement services | ||||
VWR | VWR Corporation and its subsidiaries, a company we acquired in November 2017 |
Page | |||||
(in millions)
|
March 31, 2021
|
December 31, 2020
|
|||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 172.5 | $ | 286.6 | |||||||
Accounts receivable, net of allowances of $25.6 and $26.2
|
1,201.5 | 1,113.3 | |||||||||
Inventory | 777.7 | 739.6 | |||||||||
Other current assets | 80.3 | 91.4 | |||||||||
Total current assets | 2,232.0 | 2,230.9 | |||||||||
Property, plant and equipment, net of accumulated depreciation of $400.5 and $388.3
|
537.4 | 549.9 | |||||||||
Other intangible assets, net (see note 7)
|
3,932.2 | 4,048.8 | |||||||||
Goodwill | 2,820.1 | 2,860.2 | |||||||||
Other assets | 217.1 | 216.7 | |||||||||
Total assets | $ | 9,738.8 | $ | 9,906.5 | |||||||
Liabilities and stockholders’ equity | |||||||||||
Current liabilities: | |||||||||||
Current portion of debt | $ | 26.5 | $ | 26.4 | |||||||
Accounts payable | 706.4 | 678.9 | |||||||||
Employee-related liabilities | 140.8 | 179.3 | |||||||||
Accrued interest | 26.8 | 44.5 | |||||||||
Other current liabilities | 340.2 | 313.6 | |||||||||
Total current liabilities | 1,240.7 | 1,242.7 | |||||||||
Debt, net of current portion | 4,606.3 | 4,867.5 | |||||||||
Deferred income tax liabilities | 713.0 | 723.9 | |||||||||
Other liabilities | 372.7 | 398.1 | |||||||||
Total liabilities | 6,932.7 | 7,232.2 | |||||||||
Commitments and contingencies (see note 8)
|
|||||||||||
Stockholders’ equity: | |||||||||||
MCPS including paid-in capital, 20.7 shares outstanding
|
1,003.7 | 1,003.7 | |||||||||
Common stock including paid-in capital, 581.8 and 580.1 shares outstanding
|
1,743.2 | 1,737.6 | |||||||||
Accumulated earnings (deficit)
|
75.3 | (88.7) | |||||||||
Accumulated other comprehensive (loss) income
|
(16.1) | 21.7 | |||||||||
Total stockholders’ equity | 2,806.1 | 2,674.3 | |||||||||
Total liabilities and stockholders’ equity | $ | 9,738.8 | $ | 9,906.5 |
(in millions, except per share data)
|
Three months ended March 31,
|
||||||||||||||||||||||
2021
|
2020
|
||||||||||||||||||||||
Net sales | $ | 1,785.6 | $ | 1,519.0 | |||||||||||||||||||
Cost of sales | 1,172.8 | 1,017.1 | |||||||||||||||||||||
Gross profit | 612.8 | 501.9 | |||||||||||||||||||||
Selling, general and administrative expenses | 346.5 | 343.5 | |||||||||||||||||||||
Operating income
|
266.3 | 158.4 | |||||||||||||||||||||
Interest expense | (51.5) | (94.5) | |||||||||||||||||||||
Loss on extinguishment of debt | (5.2) | — | |||||||||||||||||||||
Other income, net
|
1.8 | 0.8 | |||||||||||||||||||||
Income before income taxes
|
211.4 | 64.7 | |||||||||||||||||||||
Income tax expense
|
(47.4) | (17.7) | |||||||||||||||||||||
Net income
|
164.0 | 47.0 | |||||||||||||||||||||
Accumulation of yield on preferred stock | (16.1) | (16.1) | |||||||||||||||||||||
Net income available to common stockholders
|
$ | 147.9 | $ | 30.9 | |||||||||||||||||||
Earnings per share: | |||||||||||||||||||||||
Basic | $ | 0.25 | $ | 0.05 | |||||||||||||||||||
Diluted | $ | 0.25 | $ | 0.05 | |||||||||||||||||||
Weighted average shares outstanding: | |||||||||||||||||||||||
Basic | 581.1 | 573.7 | |||||||||||||||||||||
Diluted | 589.1 | 581.3 |
(in millions)
|
Three months ended March 31,
|
||||||||||||||||||||||
2021
|
2020
|
||||||||||||||||||||||
Net income
|
$ | 164.0 | $ | 47.0 | |||||||||||||||||||
Other comprehensive loss:
|
|||||||||||||||||||||||
Foreign currency translation — unrealized loss
|
(33.5) | (68.8) | |||||||||||||||||||||
Derivative instruments: | |||||||||||||||||||||||
Unrealized (loss) gain
|
(0.9) | 1.6 | |||||||||||||||||||||
Reclassification of loss (gain) into earnings
|
0.7 | (0.1) | |||||||||||||||||||||
Defined benefit plans: | |||||||||||||||||||||||
Unrealized gain
|
0.6 | 0.4 | |||||||||||||||||||||
Reclassification of gain into earnings
|
— | (0.1) | |||||||||||||||||||||
Other comprehensive loss before income taxes
|
(33.1) | (67.0) | |||||||||||||||||||||
Income tax effect | (4.7) | (0.4) | |||||||||||||||||||||
Other comprehensive loss
|
(37.8) | (67.4) | |||||||||||||||||||||
Comprehensive income (loss)
|
$ | 126.2 | $ | (20.4) |
(in millions)
|
Stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||
MCPS including paid-in capital | Common stock including paid-in capital | Accumulated earnings (deficit) | AOCI | Total | |||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2020
|
20.7 | $ | 1,003.7 | 580.1 | $ | 1,737.6 | $ | (88.7) | $ | 21.7 | $ | 2,674.3 | |||||||||||||||||||||||||||||
Comprehensive income (loss)
|
— | — | — | — | 164.0 | (37.8) | 126.2 | ||||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | — | 10.8 | — | — | 10.8 | ||||||||||||||||||||||||||||||||||
Accumulation of yield on preferred stock | — | — | — | (16.1) | — | — | (16.1) | ||||||||||||||||||||||||||||||||||
Stock option exercises and other common stock transactions | — | — | 1.7 | 10.9 | — | — | 10.9 | ||||||||||||||||||||||||||||||||||
Balance at March 31, 2021
|
20.7 | $ | 1,003.7 | 581.8 | $ | 1,743.2 | $ | 75.3 | $ | (16.1) | $ | 2,806.1 | |||||||||||||||||||||||||||||
Balance at December 31, 2019
|
20.7 | $ | 1,003.7 | 572.8 | $ | 1,748.1 | $ | (203.7) | $ | (85.9) | $ | 2,462.2 | |||||||||||||||||||||||||||||
Impact of new accounting standard | — | — | — | — | (1.6) | — | (1.6) | ||||||||||||||||||||||||||||||||||
Comprehensive income (loss)
|
— | — | — | — | 47.0 | (67.4) | (20.4) | ||||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | — | 9.2 | — | — | 9.2 | ||||||||||||||||||||||||||||||||||
Accumulation of yield on preferred stock | — | — | — | (16.1) | — | — | (16.1) | ||||||||||||||||||||||||||||||||||
Stock option exercises and other common stock transactions | — | — | 2.1 | 6.8 | — | — | 6.8 | ||||||||||||||||||||||||||||||||||
Balance at March 31, 2020
|
20.7 | $ | 1,003.7 | 574.9 | $ | 1,748.0 | $ | (158.3) | $ | (153.3) | $ | 2,440.1 |
(in millions)
|
Three months ended March 31,
|
||||||||||
2021
|
2020
|
||||||||||
Cash flows from operating activities: | |||||||||||
Net income
|
$ | 164.0 | $ | 47.0 | |||||||
Reconciling adjustments: | |||||||||||
Depreciation and amortization | 89.0 | 96.5 | |||||||||
Stock-based compensation expense
|
11.4 | 8.4 | |||||||||
Provision for accounts receivable and inventory | 7.9 | 16.6 | |||||||||
Deferred income tax benefit
|
(5.3) | (4.2) | |||||||||
Amortization of deferred financing costs | 3.9 | 6.9 | |||||||||
Loss on extinguishment of debt | 5.2 | — | |||||||||
Foreign currency remeasurement loss
|
2.7 | 6.7 | |||||||||
Changes in assets and liabilities: | |||||||||||
Accounts receivable | (106.8) | (80.1) | |||||||||
Inventory | (54.3) | 2.3 | |||||||||
Accounts payable | 30.3 | 67.0 | |||||||||
Accrued interest | (17.7) | 60.8 | |||||||||
Other assets and liabilities | (5.9) | 24.5 | |||||||||
Other, net | 2.5 | 0.7 | |||||||||
Net cash provided by operating activities
|
126.9 | 253.1 | |||||||||
Cash flows from investing activities: | |||||||||||
Capital expenditures | (15.1) | (12.6) | |||||||||
Other | 0.5 | 0.7 | |||||||||
Net cash used in investing activities
|
(14.6) | (11.9) | |||||||||
Cash flows from financing activities: | |||||||||||
Debt repayments | (208.6) | (63.8) | |||||||||
Payments of dividends on preferred stock | (16.1) | (16.1) | |||||||||
Proceeds received from exercise of stock options | 19.9 | 6.8 | |||||||||
Shares repurchased to satisfy employee tax obligations for vested stock-based awards | (16.2) | — | |||||||||
Net cash used in financing activities
|
(221.0) | (73.1) | |||||||||
Effect of currency rate changes on cash | (5.4) | (8.5) | |||||||||
Net change in cash and cash equivalents | (114.1) | 159.6 | |||||||||
Cash, cash equivalents and restricted cash, beginning of period | 289.2 | 189.3 | |||||||||
Cash, cash equivalents and restricted cash, end of period | $ | 175.1 | $ | 348.9 |
(in millions) | Three months ended March 31, 2020 | ||||||||||||||||
Previously reported | Adjustment | As adjusted | |||||||||||||||
Proprietary materials & consumables | $ | 533.1 | $ | (54.6) | $ | 478.5 | |||||||||||
Third party materials & consumables | 604.6 | 45.8 | 650.4 | ||||||||||||||
Services & specialty procurement | 178.0 | 13.1 | 191.1 | ||||||||||||||
Equipment & instrumentation | 203.3 | (4.3) | 199.0 | ||||||||||||||
Total | $ | 1,519.0 | $ | — | $ | 1,519.0 |
(in millions, except per share data)
|
Three months ended March 31, 2021 | ||||||||||||||||||||||||||||||||||
Earnings /(loss) (numerator) | Weighted average shares outstanding (denominator) | Earnings / (loss) per share | |||||||||||||||||||||||||||||||||
Basic | $ | 147.9 | 581.1 | $ | 0.25 | ||||||||||||||||||||||||||||||
Dilutive effect of stock-based awards | — | 8.0 | |||||||||||||||||||||||||||||||||
Diluted | $ | 147.9 | 589.1 | $ | 0.25 |
(in millions, except per share data)
|
Three months ended March 31, 2020 | ||||||||||||||||||||||||||||||||||
Earnings /(loss) (numerator) | Weighted average shares outstanding (denominator) | Earnings / (loss) per share | |||||||||||||||||||||||||||||||||
Basic | $ | 30.9 | 573.7 | $ | 0.05 | ||||||||||||||||||||||||||||||
Dilutive effect of stock-based awards | — | 7.6 | |||||||||||||||||||||||||||||||||
Diluted | $ | 30.9 | 581.3 | $ | 0.05 |
(in millions)
|
Three months ended March 31,
|
||||||||||||||||||||||
2021
|
2020
|
||||||||||||||||||||||
Net sales: | |||||||||||||||||||||||
Americas | $ | 1,035.2 | $ | 899.1 | |||||||||||||||||||
Europe | 650.4 | 544.0 | |||||||||||||||||||||
AMEA | 100.0 | 75.9 | |||||||||||||||||||||
Total | $ | 1,785.6 | $ | 1,519.0 | |||||||||||||||||||
Adjusted EBITDA: | |||||||||||||||||||||||
Americas | $ | 252.0 | $ | 190.0 | |||||||||||||||||||
Europe | 131.1 | 91.7 | |||||||||||||||||||||
AMEA | 22.6 | 13.4 | |||||||||||||||||||||
Corporate | (42.6) | (32.3) | |||||||||||||||||||||
Total | $ | 363.1 | $ | 262.8 |
(in millions)
|
Three months ended March 31,
|
||||||||||
2021
|
2020
|
||||||||||
Net income
|
$ | 164.0 | $ | 47.0 | |||||||
Interest expense | 51.5 | 94.5 | |||||||||
Income tax expense
|
47.4 | 17.7 | |||||||||
Depreciation and amortization | 89.0 | 96.5 | |||||||||
Loss on extinguishment of debt | 5.2 | — | |||||||||
Net foreign currency loss from financing activities
|
0.8 | 1.6 | |||||||||
Other stock-based compensation expense (benefit) | 0.6 | (1.1) | |||||||||
Restructuring and severance charges | 1.6 | 1.2 | |||||||||
Transaction related expenses and other | 3.0 | 1.8 | |||||||||
Integration and planning expenses | — | 3.6 | |||||||||
Adjusted EBITDA | $ | 363.1 | $ | 262.8 |
(in millions)
|
Three months ended March 31,
|
||||||||||
2021
|
2020
|
||||||||||
(1) | |||||||||||
Proprietary materials & consumables | $ | 565.2 | $ | 478.5 | |||||||
Third party materials & consumables | 758.4 | 650.4 | |||||||||
Services & specialty procurement | 219.8 | 191.1 | |||||||||
Equipment & instrumentation | 242.2 | 199.0 | |||||||||
Total | $ | 1,785.6 | $ | 1,519.0 |
(in millions)
|
March 31, 2021
|
December 31, 2020
|
|||||||||
Cash and cash equivalents | $ | 172.5 | $ | 286.6 | |||||||
Restricted cash classified as other assets | 2.6 | 2.6 | |||||||||
Total | $ | 175.1 | $ | 289.2 |
(in millions)
|
Three months ended March 31,
|
||||||||||
2021
|
2020
|
||||||||||
Cash flows from operating activities: | |||||||||||
Cash paid for income taxes, net | $ | 12.6 | $ | 12.2 | |||||||
Cash paid for interest | 64.0 | 27.2 | |||||||||
Cash paid under operating leases | 10.7 | 10.0 | |||||||||
Cash paid under finance leases | 1.3 | 1.3 | |||||||||
Cash flows from financing activities: | |||||||||||
Cash paid under finance leases | 1.1 | 1.1 |
(in millions)
|
March 31, 2021
|
December 31, 2020
|
|||||||||
Merchandise inventory | $ | 480.4 | $ | 463.0 | |||||||
Finished goods | 112.6 | 115.9 | |||||||||
Raw materials | 142.8 | 123.2 | |||||||||
Work in process | 41.9 | 37.5 | |||||||||
Total | $ | 777.7 | $ | 739.6 |
(in millions)
|
March 31, 2021
|
December 31, 2020
|
|||||||||||||||||||||||||||||||||
Gross value | Accumulated amortization | Carrying value | Gross value | Accumulated amortization | Carrying value | ||||||||||||||||||||||||||||||
Customer relationships | $ | 4,644.9 | $ | 944.2 | $ | 3,700.7 | $ | 4,701.6 | $ | 894.9 | $ | 3,806.7 | |||||||||||||||||||||||
VWR trade name | 271.5 | 184.8 | 86.7 | 275.7 | 184.3 | 91.4 | |||||||||||||||||||||||||||||
Other | 184.6 | 132.1 | 52.5 | 185.4 | 127.0 | 58.4 | |||||||||||||||||||||||||||||
Total finite-lived | $ | 5,101.0 | $ | 1,261.1 | 3,839.9 | $ | 5,162.7 | $ | 1,206.2 | 3,956.5 | |||||||||||||||||||||||||
Indefinite-lived | 92.3 | 92.3 | |||||||||||||||||||||||||||||||||
Total | $ | 3,932.2 | $ | 4,048.8 |
(dollars in millions)
|
March 31, 2021
|
December 31, 2020
|
|||||||||||||||||||||
Interest terms | Rate | Amount | |||||||||||||||||||||
Receivables facility |
LIBOR plus 0.90%
|
1.01%
|
$ | — | $ | — | |||||||||||||||||
Senior secured credit facilities: | |||||||||||||||||||||||
Euro term loans |
EURIBOR plus 2.50%
|
2.50%
|
254.7 | 344.8 | |||||||||||||||||||
U.S. dollar term loans |
LIBOR plus 2.25%
|
3.25%
|
420.7 | 546.7 | |||||||||||||||||||
U.S. dollar term loans |
LIBOR plus 2.25%
|
3.25%
|
1,172.1 | 1,175.0 | |||||||||||||||||||
2.625% secured notes | fixed rate |
2.625%
|
763.2 | 795.0 | |||||||||||||||||||
3.875% unsecured notes | fixed rate |
3.875%
|
469.6 | 489.2 | |||||||||||||||||||
4.625 % unsecured notes | fixed rate |
4.625%
|
1,550.0 | 1,550.0 | |||||||||||||||||||
Finance lease liabilities | 71.7 | 71.5 | |||||||||||||||||||||
Total debt, gross | 4,702.0 | 4,972.2 | |||||||||||||||||||||
Less: unamortized deferred financing costs | (69.2) | (78.3) | |||||||||||||||||||||
Total debt | $ | 4,632.8 | $ | 4,893.9 | |||||||||||||||||||
Classification on balance sheets: | |||||||||||||||||||||||
Current portion of debt | $ | 26.5 | $ | 26.4 | |||||||||||||||||||
Debt, net of current portion | 4,606.3 | 4,867.5 |
(in millions)
|
March 31, 2021
|
||||||||||||||||
Receivables facility | Revolving credit facility | Total | |||||||||||||||
Capacity | $ | 300.0 | $ | 515.0 | $ | 815.0 | |||||||||||
Undrawn letters of credit outstanding | (9.9) | (1.6) | (11.5) | ||||||||||||||
Outstanding borrowings | — | — | — | ||||||||||||||
Unused availability | $ | 290.1 | $ | 513.4 | $ | 803.5 | |||||||||||
Maximum availability | $ | 300.0 | $ | 515.0 | $ | 815.0 |
(in millions)
|
Foreign currency translation | Derivative instruments | Defined benefit plans | Total | |||||||||||||||||||
Balance at December 31, 2020
|
$ | 51.8 | $ | (1.0) | $ | (29.1) | $ | 21.7 | |||||||||||||||
Unrealized (loss) gain
|
(33.5) | (0.9) | 0.6 | (33.8) | |||||||||||||||||||
Reclassification of loss into earnings
|
— | 0.7 | — | 0.7 | |||||||||||||||||||
Income tax effect | (4.7) | — | — | (4.7) | |||||||||||||||||||
Balance at March 31, 2021
|
$ | 13.6 | $ | (1.2) | $ | (28.5) | $ | (16.1) | |||||||||||||||
Balance at December 31, 2019
|
$ | (62.3) | $ | (0.5) | $ | (23.1) | $ | (85.9) | |||||||||||||||
Unrealized (loss) gain
|
(68.8) | 1.6 | 0.4 | (66.8) | |||||||||||||||||||
Reclassification of gain into earnings
|
— | (0.1) | (0.1) | (0.2) | |||||||||||||||||||
Income tax effect | — | (0.4) | — | (0.4) | |||||||||||||||||||
Balance at March 31, 2020
|
$ | (131.1) | $ | 0.6 | $ | (22.8) | $ | (153.3) | |||||||||||||||
(options and intrinsic value in millions)
|
Number of options | Weighted average exercise price per option | Aggregate intrinsic value | Weighted average remaining term | |||||||||||||||||||
Balance at December 31, 2020
|
20.0 | $ | 18.80 | ||||||||||||||||||||
Granted | 1.5 | 27.70 | |||||||||||||||||||||
Exercised | (1.0) | 21.40 | |||||||||||||||||||||
Forfeited | (0.1) | 15.88 | |||||||||||||||||||||
Balance at March 31, 2021
|
20.4 | 19.32 | $ | 197.0 | 7.5 years | ||||||||||||||||||
Expected to vest | 9.0 | 19.80 | 83.2 | 8.6 years | |||||||||||||||||||
Vested | 11.4 | 18.93 | 113.7 | 6.6 years |
(awards in millions)
|
Number of awards | Weighted average grant date fair value per award | |||||||||
Balance at December 31, 2020
|
4.9 | $ | 15.31 | ||||||||
Granted | 1.1 | 29.17 | |||||||||
Vested | (0.7) | 15.38 | |||||||||
Forfeited | — | 18.51 | |||||||||
Balance at March 31, 2021
|
5.3 | 18.73 |
(in millions)
|
Three months ended March 31,
|
||||||||||||||||||||||
2021
|
2020
|
||||||||||||||||||||||
Net foreign currency loss from financing activities
|
$ | (0.8) | $ | (1.6) | |||||||||||||||||||
Income related to defined benefit plans | 2.4 | 2.3 | |||||||||||||||||||||
Other | 0.2 | 0.1 | |||||||||||||||||||||
Other income, net
|
$ | 1.8 | $ | 0.8 |
(in millions)
|
Three months ended March 31,
|
||||||||||||||||||||||
2021
|
2020
|
||||||||||||||||||||||
Income before income taxes
|
$ | 211.4 | $ | 64.7 | |||||||||||||||||||
Income tax expense
|
(47.4) | (17.7) | |||||||||||||||||||||
Effective income tax rate | 22.4 | % | 27.4 | % |
(in millions) |
Three months ended March 31,
|
||||||||||
2021 | 2020 | ||||||||||
Net investment hedges | $ | 19.6 | $ | — |
(in millions)
|
March 31, 2021
|
December 31, 2020
|
|||||||||||||||||||||
Carrying value | Fair value | Carrying value | Fair value | ||||||||||||||||||||
Receivables facility | $ | — | $ | — | $ | — | $ | — | |||||||||||||||
Senior secured credit facilities: | |||||||||||||||||||||||
Euro term loans | 254.7 | 255.7 | 344.8 | 346.5 | |||||||||||||||||||
U.S. dollar term loans | 420.7 | 421.0 | 546.7 | 548.1 | |||||||||||||||||||
U.S. dollar term loans | 1,172.1 | 1,174.3 | 1,175.0 | 1,178.7 | |||||||||||||||||||
2.625% secured notes | 763.2 | 783.1 | 795.0 | 815.7 | |||||||||||||||||||
3.875% unsecured notes | 469.6 | 496.7 | 489.2 | 515.0 | |||||||||||||||||||
4.625 % unsecured notes | 1,550.0 | 1,617.2 | 1,550.0 | 1,648.7 | |||||||||||||||||||
Finance lease liabilities | 71.7 | 71.7 | 71.5 | 71.5 | |||||||||||||||||||
Total | $ | 4,702.0 | $ | 4,819.7 | $ | 4,972.2 | $ | 5,124.2 |
(dollars in millions)
|
Three months ended March 31, | Change | |||||||||||||||
2021 | 2020 | ||||||||||||||||
Net sales | $ | 1,785.6 | $ | 1,519.0 | $ | 266.6 | |||||||||||
Gross margin | 34.3 | % | 33.0 | % | 130 bps | ||||||||||||
Operating income | $ | 266.3 | $ | 158.4 | $ | 107.9 | |||||||||||
Net income | 164.0 | 47.0 | 117.0 | ||||||||||||||
Adjusted EBITDA | 363.1 | 262.8 | 100.3 | ||||||||||||||
Adjusted EBITDA margin | 20.3 | % | 17.3 | % | 300 bps |
(in millions) |
Three months ended March 31,
|
Reconciliation of net sales growth to organic net sales growth | |||||||||||||||||||||||||||
Net sales growth | Foreign currency impact | Organic net sales growth | |||||||||||||||||||||||||||
2021
|
2020
|
||||||||||||||||||||||||||||
Americas | $ | 1,035.2 | $ | 899.1 | $ | 136.1 | $ | 4.9 | $ | 131.2 | |||||||||||||||||||
Europe | 650.4 | 544.0 | 106.4 | 51.1 | 55.3 | ||||||||||||||||||||||||
AMEA | 100.0 | 75.9 | 24.1 | 3.6 | 20.5 | ||||||||||||||||||||||||
Total | $ | 1,785.6 | $ | 1,519.0 | $ | 266.6 | $ | 59.6 | $ | 207.0 |
Three months ended March 31,
|
Change | ||||||||||||||||
2021
|
2020
|
||||||||||||||||
Gross margin | 34.3 | % | 33.0 | % | 130 bps |
(in millions)
|
Three months ended March 31,
|
Change | |||||||||||||||
2021
|
2020
|
||||||||||||||||
Gross profit | $ | 612.8 | $ | 501.9 | $ | 110.9 | |||||||||||
Operating expenses | 346.5 | 343.5 | 3.0 | ||||||||||||||
Operating income
|
$ | 266.3 | $ | 158.4 | $ | 107.9 |
(in millions)
|
Three months ended March 31,
|
Change | |||||||||||||||
2021
|
2020
|
||||||||||||||||
Operating income
|
$ | 266.3 | $ | 158.4 | $ | 107.9 | |||||||||||
Interest expense | (51.5) | (94.5) | 43.0 | ||||||||||||||
Loss on extinguishment of debt | (5.2) | — | (5.2) | ||||||||||||||
Other income, net
|
1.8 | 0.8 | 1.0 | ||||||||||||||
Income tax expense
|
(47.4) | (17.7) | (29.7) | ||||||||||||||
Net income
|
$ | 164.0 | $ | 47.0 | $ | 117.0 |
(in millions)
|
Three months ended March 31, |
Change
|
|||||||||||||||
2021 | 2020 | ||||||||||||||||
Adjusted EBITDA: | |||||||||||||||||
Americas | $ | 252.0 | $ | 190.0 | $ | 62.0 | |||||||||||
Europe | 131.1 | 91.7 | 39.4 | ||||||||||||||
AMEA | 22.6 | 13.4 | 9.2 | ||||||||||||||
Corporate | (42.6) | (32.3) | (10.3) | ||||||||||||||
Total | $ | 363.1 | $ | 262.8 | $ | 100.3 | |||||||||||
Adjusted EBITDA margin | 20.3 | % | 17.3 | % | 3.0 | % | |||||||||||
(in millions)
|
Three months ended March 31,
|
||||||||||
2021
|
2020
|
||||||||||
Net income
|
$ | 164.0 | $ | 47.0 | |||||||
Interest expense | 51.5 | 94.5 | |||||||||
Income tax expense
|
47.4 | 17.7 | |||||||||
Depreciation and amortization | 89.0 | 96.5 | |||||||||
Loss on extinguishment of debt | 5.2 | — | |||||||||
Net foreign currency loss from financing activities
|
0.8 | 1.6 | |||||||||
Other stock-based compensation expense (benefit) | 0.6 | (1.1) | |||||||||
Restructuring and severance charges1
|
1.6 | 1.2 | |||||||||
Transaction related expenses and other2
|
3.0 | 1.8 | |||||||||
Integration and planning expenses3
|
— | 3.6 | |||||||||
Adjusted EBITDA | $ | 363.1 | $ | 262.8 |
(in millions)
|
March 31, 2021 | ||||||||||||||||
Receivables facility | Revolving credit facility | Total | |||||||||||||||
Unused availability under credit facilities: | |||||||||||||||||
Capacity | $ | 300.0 | $ | 515.0 | $ | 815.0 | |||||||||||
Undrawn letters of credit outstanding | (9.9) | (1.6) | (11.5) | ||||||||||||||
Outstanding borrowings | — | — | — | ||||||||||||||
Unused availability | $ | 290.1 | $ | 513.4 | $ | 803.5 | |||||||||||
Cash and cash equivalents | 172.5 | ||||||||||||||||
Total liquidity | $ | 976.0 |
(in millions)
|
Three months ended March 31, |
Change
|
|||||||||||||||
2021 | 2020 | ||||||||||||||||
Operating activities: | |||||||||||||||||
Net income | $ | 164.0 | $ | 47.0 | 117.0 | ||||||||||||
Non-cash items | 114.8 | 130.9 | (16.1) | ||||||||||||||
Working capital changes1,2
|
(130.5) | (4.3) | (126.2) | ||||||||||||||
All other | (21.4) | 79.5 | (100.9) | ||||||||||||||
Total | $ | 126.9 | $ | 253.1 | $ | (126.2) | |||||||||||
Investing activities | $ | (14.6) | $ | (11.9) | $ | (2.7) | |||||||||||
Financing activities | (221.0) | (73.1) | (147.9) | ||||||||||||||
Capital expenditures | (15.1) | (12.6) | (2.5) |
(in millions)
|
Three months ended March 31, | Change | |||||||||||||||
2021 | 2020 | ||||||||||||||||
Net cash provided by operating activities | $ | 126.9 | $ | 253.1 | $ | (126.2) | |||||||||||
Capital expenditures | (15.1) | (12.6) | (2.5) | ||||||||||||||
Free cash flow | $ | 111.8 | $ | 240.5 | $ | (128.7) |
Exhibit no. | Exhibit description | Method of filing | ||||||||||||
Filed herewith | ||||||||||||||
Filed herewith | ||||||||||||||
Filed herewith | ||||||||||||||
Furnished herewith | ||||||||||||||
Furnished herewith | ||||||||||||||
101 | XBRL exhibits | Filed herewith | ||||||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | Filed herewith |
Avantor, Inc. | |||||||||||
Date: April 28, 2021 | By: | /s/ Steven Eck | |||||||||
Name: | Steven Eck | ||||||||||
Title: | Senior Vice President, Chief Accounting Officer (Principal Accounting Officer) |
Position:
|
Executive Vice President, Chief Information Officer | ||||
Base Salary:
|
$365,000 per year, payable in installments on Avantor’s regular payroll dates. | ||||
Duties:
|
The duties performed by you as of immediately prior to the date of this Agreement. | ||||
Reporting:
|
You will report solely and directly to the Chief Executive Officer of Avantor. | ||||
Office Location:
|
Your office will be located in Radnor, PA. | ||||
Annual Bonus:
|
You will be eligible to participate in Avantor’s Management Incentive Program (MIP) with a target bonus of 75% of base salary. | ||||
Benefits:
|
You will be entitled to participate in all vacation, health, welfare and other similar benefits available to similarly situated employees of Avantor. You will be entitled to four weeks of vacation annually. |
Severance/Restrictive Covenants: |
If your employment with Avantor is terminated by Avantor without Cause, other than within a two year period following a Change in Control (each as defined on Annex 1), you will be entitled to receive (A) an amount equal to your annual base salary then in effect, payable in equal installments on Avantor’s regular payroll dates during a period of twelve months after such termination, (B) your target bonus, prorated for the year of such termination, payable in equal installments on Avantor’s regular payroll dates during a period of twelve months after such termination and (C) continued health benefits for a period ending on the earlier of (x) your becoming eligible to receive health benefits from a new employer and (y) twelve months after such termination. The payments (and benefits) described in the immediately preceding sentence that are due to be paid (or provided) more than sixty (60) days after your termination are subject to your execution and non-revocation of a general release in the form attached to this Letter Agreement as Annex 2 no later than fifty (50) days after your termination.
|
||||
If your employment with Avantor or its successor, as applicable, is terminated by you for Good Reason (as defined on Annex 1) or by Avantor without Cause within a two year period following a Change in Control, you will be entitled to receive (A) an aggregate amount equal to 1.5 times the sum of (x) your base salary then in effect, plus (y) your target bonus for the year of such termination, payable in equal installments on Avantor’s regular payroll dates during a period
of twelve months after such termination and (B) continued health benefits for a period ending on the earlier of (x) your becoming eligible to receive health benefits from a new employer and (y) eighteen months after such termination. The payments (and benefits) described in the immediately preceding sentence that are due to be paid (or provided) more than sixty (60) days after your termination are subject to your execution and non-revocation of a general release in the form attached to this Letter Agreement as Annex 2 no later than fifty (50) days after your termination.
|
|||||
If your employment is terminated by Avantor by reason of your Disability (as defined on Annex 1), you will be entitled to any compensation and benefits accrued prior to the termination date, including Avantor’s standard applicable disability insurance benefits.
|
|||||
If your employment with Avantor is terminated by reason of your death, your beneficiary or estate, as applicable, will be entitled to any compensation and benefits accrued prior to the termination date, including Avantor’s standard applicable life insurance benefits. | |||||
If your employment is terminated by you without Good Reason, you will only be entitled to any compensation and benefits accrued prior to the termination date. Any such resignation shall require that written notice be delivered by you to Avantor at least 90 days prior to your termination and any failure by you to provide such written notice shall be considered a material breach of this Agreement by you. | |||||
If your employment is terminated by Avantor for Cause, you will only be entitled to any compensation and benefits accrued prior to the termination date. | |||||
In the event of a termination of your employment for any reason, you agree to be subject to those restrictions set forth on Annex 1 attached hereto, which are a part of this Letter Agreement (the “Employee Covenants”).
|
You shall be under no obligation to seek other employment for any reason or to mitigate any severance payments following a termination of your employment with Avantor for any reason. In addition, there shall be no offset against amounts due to you upon termination of your employment with Avantor on account of any compensation attributable to any employment subsequent to your employment with Avantor. Subject to the notice requirement as set forth above, either you or Avantor may terminate your employment with Avantor at any time. | |||||
Except as provided above in this Severance/Restrictive Covenants section, you shall not be entitled to any other salary, compensation or benefits from Avantor after termination of your employment with Avantor, except as otherwise specifically provided for in Avantor’s employee benefit plans or as otherwise expressly required by applicable law. | |||||
Notwithstanding anything herein to the contrary, if any payments due hereunder would subject you to any tax imposed under Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), as a result of your characterization as a “specified employee” of Avantor (within the meaning of Treasury Regulation Section 1.409A-1(i)), then such payments that would otherwise cause such taxation shall be payable in a single lump sum on the first
business day that is six months following your “separation from service” (within the meaning of Code Section 409A and the regulations thereunder), and any remaining payments will be made in accordance with the foregoing provisions of this section.
|
|||||
Personal Services Agreement:
|
The Personal Services, Confidentiality and Inventions Agreement, that you previously executed, in the form attached hereto as Exhibit A, shall remain in full force and effect.
|
||||
Entire Agreement:
|
This Letter Agreement, (including any Annexes attached hereto) and the Personal Services, Confidentiality and Inventions Agreement referenced above set forth the entire understanding between you and Avantor with respect to the subject matter hereof and thereof, and supersede and preempt all prior oral or written understandings and agreements with respect to the subject matter hereof and thereof between you and Avantor and its affiliates, which shall terminate and be of no further effect upon the execution of this Letter Agreement. | ||||
This Letter Agreement, and all of your rights and duties hereunder, shall not be assignable or delegable by you. Any purported assignment or delegation by you in violation of the foregoing shall be null and void ab initio and of no force and effect. This Letter Agreement may be assigned by Avantor to a person or entity which is a successor in interest to substantially all of the business operations of Avantor, or to a subsidiary or affiliate of Avantor. Upon such assignment, the rights and obligations of Avantor hereunder shall become the rights and obligations of such subsidiary, affiliate or successor person or entity.
|
Code Section 409A:
|
This Letter Agreement will be interpreted to avoid any tax under §409A of the Code. For purposes of §409A, each payment made under this Letter Agreement will be treated as a separate payment. With respect to any reimbursements provided under this Letter Agreement that are subject to §409A, the amount of expenses eligible for reimbursement during a calendar year cannot affect the
expenses eligible for reimbursement in any other calendar year. |
VWR MANAGEMENT SERVICES, LLC | ||||||||||||||
By: VWR International, LLC, its sole member | ||||||||||||||
By: /s/ Justin M. Miller | ||||||||||||||
Name: Justin M. Miller | ||||||||||||||
Title: EVP & General Counsel | ||||||||||||||
Accepted and Agreed | ||||||||||||||
/s/ Michael Wondrasch | ||||||||||||||
Michael Wondrasch | ||||||||||||||
Date: 4/5/2019 |
VAIL HOLDCO CORP | |||||||||||
Executive – Signature | |||||||||||
By: | |||||||||||
Its: | |||||||||||
Executive – Print Name |
DATE: | ||||||||||||||
Date: April 28, 2021 | By: | /s/ Michael Stubblefield | |||||||||
Name: | Michael Stubblefield | ||||||||||
Title: | President and Chief Executive Officer |
Date: April 28, 2021 | By: | /s/ Thomas A. Szlosek | |||||||||
Name: | Thomas A. Szlosek | ||||||||||
Title: |
Executive Vice President and Chief Financial Officer
(Principal Financial Officer) |
Date: April 28, 2021 | By: | /s/ Michael Stubblefield | |||||||||
Name: | Michael Stubblefield | ||||||||||
Title: | President and Chief Executive Officer |
Date: April 28, 2021 | By: | /s/ Thomas A. Szlosek | |||||||||
Name: | Thomas A. Szlosek | ||||||||||
Title: |
Executive Vice President and Chief Financial Officer
(Principal Financial Officer) |